A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TALENT trial-Reference-Cited by-同舟云学术

A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TALENT trial

Published:2020-12 Issue:12 Volume:16 Page:e997-e1004
ISSN:1969-6213
Container-title:EuroIntervention
language:
Short-container-title:EuroIntervention

Author:

Hara Hironori,Gao Chao,Kogame Norihiro,Ono Masafumi,Kawashima Hideyuki,Wang Rutao,Morel Marie-Angèle,O'Leary Neil,Sharif Faisal,Möllmann Helge,Reiber Johan H.C.,Sabaté Manel,Zaman Azfar,Wijns William,Onuma Yoshinobu,Serruys Patrick W.

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequency of periprocedural myocardial injury and infarction stratified by cardiac troponin I and cardiac troponin T;Cardiovascular Revascularization Medicine;2024-05

2. Comparison Among Ultra-Thin Coronary Stents: A Network Meta-Analysis;The American Journal of Cardiology;2024-04

3. Quantitative flow ratio for the prediction of coronary events after percutaneous coronary intervention;EuroIntervention;2024-01

4. Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology;EuroIntervention;2023-08

5. Summary of the European Society of Cardiology guidelines on dual antiplatelet therapy in patients after percutaneous coronary interventions;Kardiologia Polska;2022-10-31